Condition: LDL Cholesterol · Sponsor: LIB Therapeutics LLC
Study to assess the LDL-C lowering efficacy of different doses of LIB003 administered every 4 weeks in subjects on stable statin and/or ezetimibe therapy
This description comes directly from the study's public registry record.
Contact details are listed per location below or on the registry record.
Always discuss trial participation with your own doctor first.
| Midwest Institute For Clinical Research | Indianapolis, Indiana, United States | — |
| Louisville Metabolic and Atherosclerosis Research Center | Louisville, Kentucky, United States | — |
| Sterling Research Group | Cincinnati, Ohio, United States | — |
| The Lindner Research Center | Cincinnati, Ohio, United States | — |
| Metabolic & Atherosclerosis Research Center (MARC) | Cincinnati, Ohio, United States | — |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03549260